Enteric Disease Testing Market Intelligence Report, Growth Drivers & Forecast, 2026-2035
Enteric Disease Testing Market Outlook and Forecast
The Enteric Disease Testing Market continues to play a vital role in global healthcare by enabling the rapid identification and management of bacterial, viral, and parasitic infections affecting the gastrointestinal tract. Growing awareness of foodborne illnesses, increasing adoption of molecular diagnostic technologies, and stronger public health surveillance programs are supporting sustained demand for enteric disease testing solutions. Healthcare providers are increasingly relying on advanced diagnostic platforms to reduce diagnosis time, improve treatment decisions, and limit the spread of infectious diseases. Continuous innovation in laboratory automation, multiplex testing, and point-of-care diagnostics is further strengthening the market's long-term outlook.
In 2025, the enteric disease testing market was valued at USD 4.08 Billion. The market is projected to reach USD 5.33 Billion by 2035, expanding at a 2.7% CAGR between 2026 and 2035. While growth remains steady, rising investments in infectious disease surveillance, improved healthcare infrastructure, and expanding access to diagnostic services are expected to support continued market development. Increasing international travel, urbanization, and changing food consumption patterns are also contributing to higher testing volumes across healthcare facilities worldwide.
North America maintained its leadership in 2025, accounting for 29.27% of the enteric disease testing market, supported by advanced laboratory infrastructure, high diagnostic adoption, and well-established disease monitoring systems. Europe continues to benefit from strong regulatory frameworks, extensive public health initiatives, and widespread access to modern diagnostic technologies. Meanwhile, Asia Pacific is witnessing growing demand due to expanding healthcare investments, increasing awareness of food safety, larger patient populations, and government initiatives aimed at improving infectious disease detection and laboratory capabilities.
Among market segments, bacterial disease testing held the dominant position in 2025, capturing 62.48% of the market, reflecting the high prevalence of bacterial gastrointestinal infections and the growing need for accurate pathogen identification. Advances in PCR-based assays, multiplex diagnostic panels, and automated laboratory systems continue to improve testing efficiency and diagnostic accuracy, supporting broader clinical adoption.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14567
Top Market Trends
Growing Adoption of Multiplex Molecular Diagnostics
Healthcare providers are increasingly adopting multiplex molecular diagnostic platforms capable of detecting multiple enteric pathogens from a single patient sample. These systems significantly reduce diagnosis time while improving clinical accuracy and treatment decisions. Laboratories are investing in high-throughput molecular testing platforms that deliver faster turnaround times, minimize manual intervention, and enhance outbreak management capabilities.
Expansion of Point-of-Care Testing Solutions
Point-of-care testing is becoming increasingly important for emergency departments, rural healthcare facilities, and outpatient clinics where rapid diagnosis is essential. Compact diagnostic devices enable clinicians to identify infectious agents more quickly, improving patient management while reducing unnecessary antibiotic use. Manufacturers continue introducing portable testing platforms that simplify workflow and increase accessibility.
Increasing Focus on Foodborne Disease Surveillance
Government agencies and public health organizations are strengthening surveillance programs to detect and control foodborne disease outbreaks more effectively. Enhanced monitoring systems, digital reporting platforms, and laboratory networking initiatives are improving response times during outbreaks while supporting nationwide disease tracking and prevention efforts.
Integration of Laboratory Automation and Artificial Intelligence
Clinical laboratories are incorporating automation, digital workflow management, and artificial intelligence into diagnostic operations to improve efficiency and reduce reporting delays. Automated sample preparation, intelligent result interpretation, and integrated laboratory information systems are helping healthcare organizations manage growing testing volumes while maintaining high diagnostic quality.
Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14567
Recent Company Developments
- bioMérieux continued expanding its molecular infectious disease diagnostic portfolio through enhancements to multiplex gastrointestinal pathogen testing solutions.
- QIAGEN strengthened its sample preparation and molecular diagnostics offerings by introducing workflow improvements for infectious disease laboratories.
- Thermo Fisher Scientific expanded its PCR-based diagnostic capabilities with advanced laboratory automation solutions supporting infectious disease detection.
- Danaher Corporation (Cepheid) continued enhancing rapid molecular testing platforms designed to accelerate diagnosis across healthcare settings.
- Abbott Laboratories expanded access to molecular diagnostic technologies through continued innovation in infectious disease testing systems.
- F. Hoffmann-La Roche Ltd. invested in integrated molecular diagnostic platforms that improve laboratory productivity and clinical decision-making.
- BD (Becton, Dickinson and Company) advanced microbiology laboratory automation and infectious disease diagnostic workflow solutions for healthcare providers.
- Meridian Bioscience continued strengthening its gastrointestinal diagnostic portfolio through product enhancements and expanded distribution initiatives.
- Luminex Corporation supported broader adoption of multiplex testing technologies that enable simultaneous detection of multiple enteric pathogens.
- Seegene Inc. continued expanding multiplex PCR assay offerings designed to improve comprehensive infectious disease diagnosis across global healthcare markets.
Read more about this report @ https://www.fundamentalbusinessinsights.com/industry-report/enteric-disease-testing-market-14567
Related Reports
About Fundamental Business Insights:
Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.
Contact us:
Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email: sales@fundamentalbusinessinsights.com
Read This Report in Regional Languages –
https://www.fundamentalbusinessinsights.com/ko/industry-report/enteric-disease-testing-market-14567
https://www.fundamentalbusinessinsights.com/ja/industry-report/enteric-disease-testing-market-14567
https://www.fundamentalbusinessinsights.com/de/industry-report/enteric-disease-testing-market-14567
https://www.fundamentalbusinessinsights.com/it/industry-report/enteric-disease-testing-market-14567
https://www.fundamentalbusinessinsights.com/es/industry-report/enteric-disease-testing-market-14567
https://www.fundamentalbusinessinsights.com/fr/industry-report/enteric-disease-testing-market-14567
